PRODUCT

KPV (10 mg Vial)

No short description available.

Quickstart Highlights

KPV (Lysine–Proline–Valine) is a C‑terminal tripeptide fragment of α‑melanocyte‑stimulating hormone (α‑MSH) studied for its potent anti‑inflammatory properties without melanotropic side effects[1][2]. Research demonstrates KPV reduces pro‑inflammatory cytokines in models of inflammatory bowel disease and systemic inflammation[3]. This educational protocol presents a once‑daily subcutaneous approach using a practical dilution for precise insulin‑syringe measurements.

Reconstitute: Add 3.0 mL bacteriostatic water → ~3.33 mg/mL concentration.
Typical daily range: 200–500 mcg once daily (gradual titration recommended).
Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.33 mcg on a U‑100 insulin syringe.
Storage: Lyophilized: freeze at −20 °C (−4 °F) or below; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 30 days; avoid freeze–thaw cycles.

Research Indications

Inflammation

effective

Systemic Inflammation
Reduces circulating inflammatory markers like TNF-α and IL-6
Autoimmune Modulation
May help balance overactive immune responses
Joint Inflammation
Potential benefits for inflammatory arthritis

Guthealth

effective

IBD Support
Shows promise for Crohn's disease and ulcerative colitis
Intestinal Barrier
Helps repair and maintain gut barrier integrity
Microbiome Balance
Selective antimicrobial effects preserve beneficial bacteria

Immunefunction

effective

Cytokine Regulation
Normalizes inflammatory cytokine production
Immune Balance
Helps shift from Th1/Th17 to regulatory T cell responses
Infection Response
Maintains antimicrobial defense while reducing inflammation

Reconstitution

Draw 3.0 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake).
Label and refrigerate at 2–8 °C (35.6–46.4 °F) , protected from light.
Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Interactions

BPC-157

Synergistic

Complementary gut healing mechanisms - BPC-157 promotes tissue repair while KPV reduces inflammation

TB-500

Compatible

Both have anti-inflammatory properties through different pathways - may work well together

LL-37

Synergistic

Both are antimicrobial peptides - KPV focuses on inflammation while LL-37 on direct antimicrobial action

Thymosin Alpha-1

Compatible

Different immune modulation mechanisms - TA1 enhances immune function while KPV reduces inflammation

GHK-Cu

Synergistic for Skin

Excellent combination for skin health - GHK-Cu promotes collagen while KPV reduces inflammation

Melanotan II

Use Caution

KPV is derived from α-MSH like MT-II but without tanning effects - using both is unnecessary

Protocol Overview

Goal:Support reduction of systemic inflammation and modulate immune responses without melanotropic effects[1][3].
Schedule:Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired).
Dose Range:200–500 mcg daily with gradual weekly titration.
Reconstitution:3.0 mL per 10 mg vial (~3.33 mg/mL) for accurate unit measurements.
Storage:Lyophilized frozen at −20 °C (−4 °F) or below; reconstituted refrigerated at 2–8 °C (35.6–46.4 °F); avoid repeated freeze–thaw.

Dosage Protocols

Start:200 mcg daily; increase by ~100 mcg weekly as tolerated[4][5].
Target:400–500 mcg daily by Weeks 4–8 for maintenance anti‑inflammatory effects.
Frequency:Once per day (subcutaneous).
Cycle Length:8–12 weeks; optional extension to 16 weeks under monitoring.
Timing:Any consistent time; rotate injection sites systematically.

Dosage Protocols

General Anti-Inflammatory:200-300mcgOnce daily
Active Inflammation:250mcgTwice daily
Autoimmune Support:500mcgOnce daily
Acute Flare-ups:500mcgTwice daily for 1 week then reduce

Route:injectable

Storage Instructions

Lyophilized:Store at −20 °C (−4 °F) or below in dry, dark conditions; protect from moisture and light[6][7].
Reconstituted:Refrigerate at 2–8 °C (35.6–46.4 °F); use within approximately 30 days[7].

Important Notes

Practical considerations for consistency and safety.

Use new sterile insulin syringes for each administration; dispose in a sharps container immediately after use.
Rotate injection sites systematically (abdomen, thighs, upper arms) at least 1–2 inches apart to reduce local irritation and prevent lipohypertrophy[8].
Inject slowly; wait a few seconds before withdrawing the needle to prevent solution backflow.
Document daily dose, injection site, and any observations to maintain consistency and track tolerability.
If injection‑site reactions (redness, mild swelling) occur, apply a cool compress and monitor; persistent reactions warrant protocol review.

Reconstitution

Clean vial top with alcohol pad
Add 1mL bacteriostatic water to 1mg vial (creates 1000mcg/mL)
For easier dosing: Add 2mL to 1mg vial (creates 500mcg/mL)
Gently swirl to mix - KPV dissolves easily
Solution should be clear and colorless
Label with concentration and date

Route:injectable

How It Works

KPV is the C‑terminal tripeptide sequence (residues 11–13) of α‑melanocyte‑stimulating hormone (α‑MSH), retaining potent anti‑inflammatory activity without the hormone’s melanotropic effects[1][2]. Preclinical studies demonstrate KPV reduces pro‑inflammatory cytokines (TNF‑α, IL‑6, IL‑1β) and modulates immune cell activity in models of inflammatory bowel disease, colitis, and systemic inflammation[3]. The peptide’s mechanism involves inhibition of nuclear factor kappa B (NF‑κB) signaling and modulation of inflammatory mediator release[2]. Subcutaneous administration provides systemic delivery with rapid absorption and sustained anti‑inflammatory effects observed in daily dosing protocols[4].

Lifestyle Factors

Anti‑inflammatory diet: Emphasize whole foods, omega‑3 fatty acids, polyphenols, and minimize processed foods and refined sugars.
Stress management: Chronic stress elevates inflammatory markers; incorporate stress‑reduction practices (meditation, yoga, adequate sleep).
Physical activity: Regular moderate exercise supports healthy inflammatory balance; avoid overtraining which can increase inflammation.
Sleep optimization: Prioritize 7–9 hours of quality sleep nightly to support immune regulation and inflammatory homeostasis.
Gut health: Support microbiome diversity through probiotic‑rich foods and adequate fiber intake, particularly relevant for inflammatory bowel conditions.

Injection Technique

Clean the vial stopper and injection site with alcohol swabs; allow to dry completely (10–15 seconds).
Pinch a 1–2 inch skinfold; insert the needle at 45–90° angle into subcutaneous tissue[8].
Do not aspirate for subcutaneous injections; inject slowly and steadily over 3–5 seconds.
Withdraw the needle smoothly and apply gentle pressure with a clean alcohol swab (do not rub the site).
Rotate sites systematically using a pattern (e.g., alternating between right/left abdomen, right/left thigh) to avoid lipohypertrophy and maintain consistent absorption[9].
Preferred sites: abdomen (at least 2 inches from navel), anterior/lateral thigh, or outer upper arm (if administering to self, abdomen and thigh are easiest).

Benefits and Side Effects

Benefits

Anti‑inflammatory activity: Reduces pro‑inflammatory cytokines and modulates immune responses in models of inflammatory bowel disease and systemic inflammation[3].
Oral and subcutaneous efficacy: Multiple routes of administration show activity, with subcutaneous injection favored for systemic delivery and consistent bioavailability[4].
Wound healing support: Preclinical data suggest KPV may support tissue repair and wound healing processes through inflammatory modulation[5].

Side Effects

No melanotropic effects: Unlike full α‑MSH, KPV does not affect melanocyte activity or skin pigmentation[1].

KPV (10 mg Vial)

Resources

Categories

Company